Insilico launches AI-driven longevity vaccines research for aging-related diseases and human longevity

Nature Biotechnology | Insilico’s AI-driven IPF candidate rentosertib shows potential for biological age reversal, as assessed by six proteomic aging clocks

Dogs may hold surprising clues to human longevity

Weekly Event Preview | Insilico’s Dr. Alex Aliper to attend dual Hong Kong summits to unlock AI-driven healthcare innovations